Lambert-Eaton myasthenic syndrome: Difference between revisions

No edit summary
Line 20: Line 20:
==Differential Diagnosis==
==Differential Diagnosis==
{{Weakness DDX}}
{{Weakness DDX}}
==Diagnosis==


==Treatment==
==Treatment==
Line 31: Line 33:
*[[Myasthenia Gravis]]
*[[Myasthenia Gravis]]


==Source==
==References==
Tintinalli


[[Category:Neuro]]
[[Category:Neuro]]

Revision as of 13:57, 20 July 2015

Background

  • Autoantibodies against Ca channels of axon nerve terminals responsible for ACh release
  • Epidemiology
    • Predominantly a disease a/w older men w/ history of cigarette smoking and lung cancer
      • 50% of pts have concurrent small-cell lung cancer
    • Syndrome can precede detection of malignancy by several years

Clinical Features

  • Fluctuating symmetric weakness and fatigue, esp of proximal leg muscles
  • Improvement in strength with sustained or repeated exercise (in contrast to MG)
    • Lambert sign: handshake strength increases over several seconds
  • Myalgias
  • Muscle stiffness (especially in hip and shoulders)
  • Paresthesias
  • Metallic taste
  • Autonomic symptoms (dry mouth, impotence)
  • Eye movements are unaffected
  • Sensory examination normal

Differential Diagnosis

Weakness

Diagnosis

Treatment

  • Supportive (progression to respiratory or bulbar failure is rare)
  • Acetylcholinesterase inhibitors (e.g. pyridostigmine) can improve symptoms

Disposition

  • Admission required when infectious complications occur or when severe disability requires inpatient immunotherapy

See Also

References